(Source: MARKETWIRE)
Elsevier Business Intelligence, the medtech industry's leading
strategic partner and investment conference organizer, announced
today that it will host the largest annual strategic partnership and
investment meeting, 'IN3 Medical Device Summit,' on October 20-21 at
San Francisco's InterContinental Mark Hopkins Hotel. This event
follows Elsevier Business Intelligence's 'Medical Device Investor
Day,' also being held at the InterContinental Mark Hopkins, on October
19.
IN3 Medical Device Summit is the largest annual strategic partnership
and investment meeting for senior-level medical technology executives.
Hundreds of venture capital firms and medical technology companies are
expected to attend IN3 Medical Device Summit on October 20 and 21 to
hear about the latest innovations and investment opportunities from
more than 50 emerging medical technology companies seeking funding
and/or strategic partnerships.
Investment firms that are currently registered to attend or present
at the IN3 Medical Device Summit include: Aberdare Ventures,
Abingworth Management, Agate Medical Investments, Alta Partners,
Arboretum Ventures, Ascension Health Ventures, Baird Venture
Partners, CHL Medical Partners, Covidien Ventures, De Novo Ventures,
Euclid SR Partners, Extera Partners, Frazier Healthcare Ventures, IDG
Ventures, MB Venture Partners, Medventures Associates, Montreaux
Equity Partners, ONSET Ventures, Polaris Venture Partners, Prospect
Venture Partners, PTV Sciences, Safeguard Scientifics, Saints
Capital, Sanderling Ventures, Scale Venture Partners, Skyline
Ventures, US Venture Partners, Versant Ventures, and Waveland Capital
Partners.
For more information about Medical Device Investor Day and IN3
Medical Device Summit, visit www.meddevicesummit.com or contact Kristy
Grimes at 480-985-9512, 888-290-2225 (U.S. toll-free), or email
IN3@elsevier.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with
the global science and health communities, Elsevier's 7,000 employees
in over 70 offices worldwide publish more than 2,000 journals and
1,900 new books per year, in addition to offering a suite of
innovative electronic products, such as Science Direct
(www.sciencedirect.com), MDConsult (www.mdconsult.com), Nursing
Consult (www.nursingconsult.com), Scopus (www.info.scopus.com),
bibliographic databases, and online reference works.
Elsevier (www.elsevier.com) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is
part of Reed Elsevier Group plc (www.reedelsevier.com), a
world-leading publisher and information provider. Operating in the
science and medical, legal, education and business-to-business
sectors, Reed Elsevier provides high-quality and flexible information
solutions to users, with increasing emphasis on the Internet as a
means of delivery. Reed Elsevier's ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108
SOURCE: Elsevier Business Intelligence
A service of YellowBrix, Inc.
